Cargando…
Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
Background. Treatment and management strategies for asthma in children are generally consistent internationally, but prescription of antiasthma drugs differs among countries. The objective of this study was to examine the prescribing patterns of antiasthma drugs, particularly controller medications,...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784626/ https://www.ncbi.nlm.nih.gov/pubmed/27335952 http://dx.doi.org/10.1177/2333794X15577790 |
_version_ | 1782420296259600384 |
---|---|
author | Hamada, Shota Tokumasu, Hironobu Sato, Akira Iwasaku, Masahiro Kawakami, Koji |
author_facet | Hamada, Shota Tokumasu, Hironobu Sato, Akira Iwasaku, Masahiro Kawakami, Koji |
author_sort | Hamada, Shota |
collection | PubMed |
description | Background. Treatment and management strategies for asthma in children are generally consistent internationally, but prescription of antiasthma drugs differs among countries. The objective of this study was to examine the prescribing patterns of antiasthma drugs, particularly controller medications, in children. Methods. A retrospective cohort study was performed in children with asthma using an administrative claims database in Japan. Results. A total of 1149 preschool-age and 3226 school-age children were identified. Leukotriene receptor antagonists were prescribed for about 80% of the children. Long-acting β-agonists were prescribed for 87.6% and 59.6% of preschool-age and school-age children, respectively, whereas prescriptions of inhaled corticosteroids had lower rates of 8.2% and 16.5%, respectively. In an examination of prescriptions at 1-month intervals, a relatively high number of children were prescribed bronchodilators without anti-inflammatory agents. Conclusion. Our findings suggest that asthma care for children in Japan can be improved through changes in drug prescriptions. |
format | Online Article Text |
id | pubmed-4784626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-47846262016-06-22 Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database Hamada, Shota Tokumasu, Hironobu Sato, Akira Iwasaku, Masahiro Kawakami, Koji Glob Pediatr Health Original Article Background. Treatment and management strategies for asthma in children are generally consistent internationally, but prescription of antiasthma drugs differs among countries. The objective of this study was to examine the prescribing patterns of antiasthma drugs, particularly controller medications, in children. Methods. A retrospective cohort study was performed in children with asthma using an administrative claims database in Japan. Results. A total of 1149 preschool-age and 3226 school-age children were identified. Leukotriene receptor antagonists were prescribed for about 80% of the children. Long-acting β-agonists were prescribed for 87.6% and 59.6% of preschool-age and school-age children, respectively, whereas prescriptions of inhaled corticosteroids had lower rates of 8.2% and 16.5%, respectively. In an examination of prescriptions at 1-month intervals, a relatively high number of children were prescribed bronchodilators without anti-inflammatory agents. Conclusion. Our findings suggest that asthma care for children in Japan can be improved through changes in drug prescriptions. SAGE Publications 2015-04-02 /pmc/articles/PMC4784626/ /pubmed/27335952 http://dx.doi.org/10.1177/2333794X15577790 Text en © The Author(s) 2015 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm). |
spellingShingle | Original Article Hamada, Shota Tokumasu, Hironobu Sato, Akira Iwasaku, Masahiro Kawakami, Koji Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database |
title | Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database |
title_full | Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database |
title_fullStr | Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database |
title_full_unstemmed | Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database |
title_short | Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database |
title_sort | asthma controller medications for children in japan: analysis of an administrative claims database |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784626/ https://www.ncbi.nlm.nih.gov/pubmed/27335952 http://dx.doi.org/10.1177/2333794X15577790 |
work_keys_str_mv | AT hamadashota asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase AT tokumasuhironobu asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase AT satoakira asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase AT iwasakumasahiro asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase AT kawakamikoji asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase |